QMSMEDI
1 call
Concalls & earnings callsQMS Medical Allied Services Limited
Every summarised call, newest first. Latest is Q1 FY27, held 17 Aug 2026.
Latest quarter
Q1 FY27 snapshot
Open full brief →Q1 FY27 saw strong revenue and profit growth driven by scaling service business (Patient Support Programs) and strategic investments beginning to yield results.
| Metric | This quarter | Change | Five-quarter trend |
|---|---|---|---|
| Consolidated Revenue | ₹56.9 Cr | +22% YoY growth | |
| EBITDA | ₹8.3 Cr | +27% YoY growth | |
| EBITDA Margin | 14.6% | Improvement vs 14.1% in Q1 FY26 and 13.3% in Q4 FY26 | |
| PAT | ₹4 Cr | +25% YoY growth |
Latest guidance
- Maintain FY27 revenue guidance of ~INR220 crores.
- Maintain FY27 EBITDA margin guidance of ~18%.
- Service revenue visibility of INR90-100 crores for FY27.
- Aiming to acquire remaining 24% stake in Saarathi Healthcare by end of Q2 FY27.
Said on the Q1 FY27 call.
Call history
- Q1 FY27Positive tone
Q1 FY27 saw strong revenue and profit growth driven by scaling service business (Patient Support Programs) and strategic investments beginning to yield results.
- Consolidated Revenue
- ₹56.9 Cr+22% YoY growth
- EBITDA
- ₹8.3 Cr+27% YoY growth